Data updated: Mar 10, 2026
ABILIFY MYCITE KIT
ARIPIPRAZOLE
Approved 2017-11-13
1
Indication
--
Phase 3 Trials
8
Years on Market
Details
- Status
- Discontinued
- First Approved
- 2017-11-13
- Routes
- ORAL
- Dosage Forms
- TABLET
ABILIFY MYCITE KIT Approval History
Loading approval history...
What ABILIFY MYCITE KIT Treats
1 FDA approvalsOriginally approved for its first indication in 2017 .
- Other (1)
🔬
Pro Active Pipeline
Ongoing clinical trials by development phase
Loading...
⭐
Pro Key Completed Trials
Completed studies with published results, ranked by significance
Loading...
📊
Trial Timeline
Full development history with FDA approval milestones
Loading...
Understanding FDA Approval Types
| Count | Type | What it means |
|---|---|---|
| - | ORIG | Original approval - drug first enters market |
| - | SUPPL - Efficacy | New indication (new disease/condition approved) |
| - | SUPPL - Labeling | Label text changes (warnings, dosing updates) |
| - | SUPPL - Manufacturing | Production changes (new facility) |
| - | SUPPL - Chemistry | Formulation changes (new dosage strength) |
Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.
ABILIFY MYCITE KIT FDA Label Details
ProABILIFY MYCITE KIT Patents & Exclusivity
Latest Patent: Oct 2033
Patents (972 active)
US9268909
Expires Oct 15, 2033
US10517507
Expires Jun 13, 2032
US9320455
Expires Dec 15, 2031
US11229378
Expires Jul 11, 2031
US8547248
Expires Dec 18, 2030
US8258962
Expires Nov 25, 2030
US8961412
Expires Nov 17, 2030
US9941931
Expires Nov 4, 2030
US11464423
Expires Sep 15, 2030
US8114021
Expires Jun 21, 2030
+ 962 more patents
Source: FDA Orange Book
Want competitive intelligence?
See who's developing similar drugs and track their progress
Data Sources
Data sourced from official FDA and NIH databases. Click links to verify on original sources.